Strides Pharma Science shines on getting nod to acquire 100% stake in Strides Pharma Services
Strides Pharma Science is currently trading at Rs. 479.80, up by 21.15 points or 4.61% from its previous closing of Rs. 458.65 on the BSE.
The scrip opened at Rs. 458.00 and has touched a high and low of Rs. 485.50 and Rs. 458.00 respectively. So far 32126 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 488.85 on 01-Aug-2023 and a 52 week low of Rs. 268.40 on 21-Mar-2023.
Last one week high and low of the scrip stood at Rs. 485.50 and Rs. 433.80 respectively. The current market cap of the company is Rs. 4328.75 crore.
The promoters holding in the company stood at 28.07%, while Institutions and Non-Institutions held 36.72% and 35.21% respectively.
Strides Pharma Science has received approval for acquisition of 100% shareholding in Strides Pharma Services (SPSPL). SPSPL is currently a wholly owned subsidiary (WOS) of Arco Lab, a WOS of the company. Post the said acquisition, SPSPL shall be a direct WOS of the company. The Board of Directors of the company at their meeting held on September 7, 2023, has approved the same.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
